Merck KGaA Selects PRA’s Remote Patient Monitoring Platform for Human Growth Hormone Treatment System

  • by

Shots:

  • Merck KGaA selects PRA’s remote patient monitoring platform to work in combination with its HGH treatment system
  • PRA’s remote patient monitoring platform will support Merck’s KGH system including its growlink (mobile app) and easypod connect (HCP platform) to monitor patient adherence, review injection history, and share information about the progress of patients with GHD
  • The addition of a patient monitoring platform to HGH treatments better facilitates patient engagement, helps HCPs to make better use of patient visits, and ensures the treatment is taken regularly and at the right dosage, optimizing treatment outcome and driving payer confidence

Click here to­ read full press release/ article | Ref: Globe Newswire | Image: Outsourcing Pharma

The post Merck KGaA Selects PRA’s Remote Patient Monitoring Platform for Human Growth Hormone Treatment System first appeared on PharmaShots.